We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Siemens and SurgiVision to Develop MRI-Guided Cardiac Electrophysiology System

By HospiMedica International staff writers
Posted on 24 Sep 2009
Siemens Healthcare (Erlangen, Germany) and SurgiVision (Irvine, CA, USA) have announced an agreement for the codevelopment and commercialization of a real-time magnetic resonance image (MRI)-guided cardiac electrophysiology (EP) system for diagnosing and treating atrial fibrillation (AF). More...


The two companies are collaborating with the University of Utah (Salt lake City, USA) to develop a fully integrated, groundbreaking EP MRI system that promises to improve conventional catheter-based cardiac procedures. In May 2009, the university opened an integrated EP-MRI clinical and research lab, which provides real-time delayed enhancement MRI for treating AF patients. The MRI's three-dimensional (3D) imaging provides greater resolution of the heart tissue than the two-dimensional images typically used, giving physicians a more precise and powerful tool for diagnosis and treatment.

"Siemens' scanner technologies, platform for interactive real-time guidance, and market leadership in MRI are second to none. By bringing together Siemens' capabilities with SurgiVision's technologies and expertise in real-time MRI-guided interventions, we are well-positioned to deliver a fully integrated hardware, software, and catheter system that will provide real-time visualization within an intuitive physician interface and a procedure that eliminates radiation exposure," said Kimble Jenkins, CEO of SurgiVision. "Our close research collaboration with the University of Utah rounds out our team with deep clinical expertise and broad research capabilities."

"We are excited to work with SurgiVision in the development of these important technologies that have the potential to significantly improve therapies for patients suffering from cardiac arrhythmias, in particular atrial fibrillation," added Walter Märzendorfer, CEO of the MR division at Siemens Healthcare.

"We are refining image-based cardiac ablation procedures using MRI, which our research indicates has the potential to improve the accuracy of the ablation, prevent complications, and decrease the number of repeat procedures," said Nassir Marrouche, M.D., an electrophysiologist and director of the University of Utah's atrial fibrillation program.


Related Links:
Siemens Healthcare
SurgiVision
University of Utah


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Vessel Sealing Instrument
ERGOseal
New
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.